Global Real-World Outcomes of Patients Receiving Immuno-Oncology Combinations for Advanced Renal Cell Carcinoma: The ARON-1 Study.
Matteo SantoniFrancesco MassariZin W MyintRoberto IacovelliMartin PichlerUmberto BassoJindrich KopeckyJakub KucharzSebastiano ButiMimma RizzoLuca GalliThomas BüttnerUgo De GiorgiRavindran KanesvaranOndřej FialaEnrique GrandePaolo Andrea ZucaliGiuseppe FornariniMaria T BourlonSarah ScagliariniJavier Molina-CerrilloGaetano AurilioMarc R MatranaRenate PichlerCarlo CattriniTomas BüchlerEmmanuel SerontFabio CalabròAlvaro PintoRossana BerardiAnca ZguraGiulia MammoneJawaher AnsariFrancesco AtzoriRita ChiariAristotelis BamiasOrazio CaffoGiuseppe ProcopioMaria BassanelliSara MerlerCarlo MessinaZsófia KüronyaAlessandra MoscaDipen BhuvaNuno VauLorena IncorvaiaSara Elena RebuzziGiandomenico RovielloIgnacio Ortego ZabalzaAlessandro RizzoVeronica MollicaGiulia SorgentoniFernando Sabino M MonteiroRodolfo MontironiNicola BattelliCamillo PortaPublished in: Targeted oncology (2023)
NCT05287464.